Long-term SGLT2 inhibitor therapy improves myocardial strain and diastolic function in HFpEF: a retrospective study linking functional recovery to reduced myocardial fibrosis - Poll - MDSpire

SGLT2 Inhibitor Therapy Enhances Myocardial Strain and Diastolic Function in Patients with HFpEF: A Retrospective Analysis Linking Functional Improvement to Decreased Myocardial Fibrosis

  • By

  • Xiaojin Xu

  • Hongyang Liu

  • Runyang Chen

  • July 21, 2026

Share

Original Source(s)

Related Content